Literature DB >> 25467646

Management of Cryptococcus gattii meningoencephalitis.

Carlos Franco-Paredes1, Tanea Womack2, Teri Bohlmeyer2, Brenda Sellers2, Allison Hays2, Kalpesh Patel3, Jairo Lizarazo4, Shawn R Lockhart5, Wajid Siddiqui2, Kieren A Marr6.   

Abstract

Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii. By inhalation and subsequent pulmonary infection, it may disseminate to the CNS and cause meningitis or meningoencephalitis. Most cases occur in immunosuppressed hosts, including patients with HIV/AIDS, patients receiving immunosuppressing drugs, and solid organ transplant recipients. However, cryptococcosis also occurs in individuals with apparently healthy immune systems. A growing number of cases are caused by C gattii, with infections occurring in both immunosuppressed and immunocompetent individuals. In the majority of documented cases, treatment of C gattii infection of the CNS requires aggressive management of raised intracranial pressure along with standard antifungal therapy. Early cerebrospinal fluid evacuation is often needed through placement of a percutaneous lumbar drain or ventriculostomy. Furthermore, pharmacological immunosuppression with a high dose of dexamethasone is sometimes needed to ameliorate a persistently increased inflammatory response and to reduce intracranial pressure. In this Grand Round, we present the case of an otherwise healthy adolescent female patient, who, despite aggressive management, succumbed to C gattii meningoencephalitis. We also present a review of the existing literature and discuss optimum clinical management of meningoencephalitis caused by C gattii.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25467646      PMCID: PMC4481715          DOI: 10.1016/S1473-3099(14)70945-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  70 in total

Review 1.  Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.

Authors:  Karen F Macsween; Tihana Bicanic; Annemarie E Brouwer; Henry Marsh; Derek C Macallan; Thomas S Harrison
Journal:  J Infect       Date:  2005-11       Impact factor: 6.072

2.  Lymphatic drainage of the brain.

Authors:  M Földi; B Csillik; O T Zoltán
Journal:  Experientia       Date:  1968-12-15

3.  Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications.

Authors:  S C Lee; D W Dickson; A Casadevall
Journal:  Hum Pathol       Date:  1996-08       Impact factor: 3.466

4.  The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.

Authors:  Graeme F Woodworth; Matthew J McGirt; Michael A Williams; Daniele Rigamonti
Journal:  Surg Neurol       Date:  2005-06

Review 5.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

Review 6.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.

Authors:  S C Lee; A Casadevall; D W Dickson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 8.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

9.  Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing.

Authors:  K R Klein; L Hall; S M Deml; J M Rysavy; S L Wohlfiel; N L Wengenack
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

10.  A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.

Authors:  Edmond J Byrnes; Wenjun Li; Ping Ren; Yonathan Lewit; Kerstin Voelz; James A Fraser; Fred S Dietrich; Robin C May; Sudha Chaturvedi; Sudha Chatuverdi; Vishnu Chaturvedi; Vishnu Chatuverdi; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more
  36 in total

1.  [Early ventricle-atrium shunts for treating cryptococcal meningitis in children].

Authors:  Shi-Qi Guang; Fang He; Li-Wen Wu; Fei Yin; Jing Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

Review 2.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

Review 3.  Cryptococcus gattii Genotype VGIIa Infection in an Immunocompetent Japanese Patient: A Case Report and Mini-review.

Authors:  Makoto Nakao; Hideki Muramatsu; Tetsushi Takahashi; Shunsuke Niwa; Yusuke Kagawa; Ryota Kurokawa; Kazuki Sone; Yuki Uozumi; Misako Ohkusu; Katsuhiko Kamei; Hiroshi Koga
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

4.  Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.

Authors:  P F Herkert; F Hagen; G L de Oliveira Salvador; R R Gomes; M S Ferreira; V A Vicente; M D Muro; R L Pinheiro; J F Meis; F Queiroz-Telles
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-01       Impact factor: 3.267

Review 5.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

Review 6.  The Frozen Brain State of Cryptococcus gattii: A Globe-Trotting, Tropical, Neurotropic Fungus.

Authors:  Paul T Akins; Brian Jian
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

Review 7.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

8.  Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.

Authors:  Mai Lee Yang; John Uhrig; Kiem Vu; Anil Singapuri; Michael Dennis; Angie Gelli; George R Thompson
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

9.  Differential In Vitro Cytokine Induction by the Species of Cryptococcus gattii Complex.

Authors:  Patricia F Herkert; Jessica C Dos Santos; Ferry Hagen; Fatima Ribeiro-Dias; Flávio Queiroz-Telles; Mihai G Netea; Jacques F Meis; Leo A B Joosten
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 10.  Cryptococcosis complicating diabetes mellitus: a scoping review.

Authors:  Lauryn Nsenga; Jonathan Kajjimu; Ronald Olum; Sandra Ninsiima; Andrew Peter Kyazze; Phillip Ssekamatte; Davis Kibirige; Joseph Baruch Baluku; Irene Andia-Biraro; Felix Bongomin
Journal:  Ther Adv Infect Dis       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.